- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06638658
Postoperative Complications of Orthopedic Surgery in Patients From High-altitude Regions
October 10, 2024 updated by: Chunling Jiang, West China Hospital
Postoperative Complications of Orthopedic Surgery in Patients From High-altitude Regions: a Cohort Study.
This study will focus on orthopedic surgery patients from high-altitude regions, utilizing smart wearables and monitoring tools to gather perioperative data, including heart rate, oxygen saturation, sleep quality, stress levels, and other relevant metrics.
Regular follow-ups will assess recovery and complications, in addition to collecting medical records, lab results, imaging data, and other pertinent records.
The ultimate goal is to establish a comprehensive follow-up cohort of orthopedic surgery patients from high-altitude areas.
Study Overview
Status
Not yet recruiting
Detailed Description
Prolonged exposure to hypoxic and low-pressure environments leads to structural remodeling and functional abnormalities in the cardiovascular, respiratory, and hematological systems of high-altitude populations.
This elevates the risk of postoperative complications, particularly in patients undergoing orthopedic surgery, significantly impacting their recovery and quality of life.
This study will focus on orthopedic surgery patients from high-altitude regions.
Using smart wearable devices and other monitoring tools, comprehensive perioperative dynamic data of participants, including heart rate, heart rate variability, oxygen saturation, respiratory rate, sleep quality, activity levels, stress index, and other relevant indicators will be collected.
Regular follow-ups will be conducted to evaluate postoperative recovery and monitor the incidence of perioperative complications.
Additionally, perioperative data such as electronic medical records, laboratory test results, ECG waveforms, echocardiography, chest CT images, and other pertinent records will be also collected.
Through that, this study aims to establish a follow-up cohort of orthopedic surgery patients from high-altitude regions.
Study Type
Observational
Enrollment (Estimated)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chunling Jiang, PhD
- Phone Number: +86 02885422114
- Email: jiangchunling@scu.edu.cn
Study Contact Backup
- Name: Fengming Luo, phD
- Phone Number: +86 85423593
- Email: jiangchunling@scu.edu.cn
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Patients who have lived in high-altitude regions scheduled for orthopedic surgery.
Description
Inclusion Criteria:
- Age ≥ 18 years;
- ASA classification I-III;
- Patients who have lived at an altitude above 2500 meters for more than 6 months ;
- Patients scheduled for elective orthopedic surgery.
Exclusion Criteria:
- Urgent or emergent surgery;
- Expected hospital stay < 48 hours;
- Inability to provide informed consent;
- Patients who have been out of high-altitude regions for over three months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Orthopedic surgery patients from high-altitude regions
high altitude patients Undergoing orthopedic surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative venous thromboembolism
Time Frame: During hospitalization
|
Defined according to the European Perioperative Clinical Outcome (EPCO) criteria, including both deep vein thrombosis and pulmonary embolism.
|
During hospitalization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative venous thromboembolism
Time Frame: Up to 2 weeks postoperatively
|
Defined according to the European Perioperative Clinical Outcome (EPCO) criteria, including both deep vein thrombosis and pulmonary embolism.
|
Up to 2 weeks postoperatively
|
|
A composite of postoperative pulmonary complications
Time Frame: During hospitalization
|
Defined according to the European Perioperative Clinical Outcome (EPCO) criteria, including respiratory infection, respiratory failure, pleural effusion, atelectasis, pneumothorax, bronchospasm, and aspiration pneumonia.
|
During hospitalization
|
|
Postoperative major adverse cardiovascular events
Time Frame: During hospitalization
|
Defined according to the European Perioperative Clinical Outcome (EPCO) criteria, including non-fatal cardiac arrest, acute myocardial infarction, congestive heart failure, new cardiac arrhythmias, angina, et al.
|
During hospitalization
|
|
Postoperative nausea and vomiting
Time Frame: During hospitalization
|
Nausea and vomiting
|
During hospitalization
|
|
The quality of postoperative recovery
Time Frame: During hospitalization
|
Assessed using QoR-15 score at different time points after surgery
|
During hospitalization
|
|
Chronic pain after surgery
Time Frame: Up to 1 year postoperatively
|
Assessed using NRS scale and BPI at different time points after surgery
|
Up to 1 year postoperatively
|
|
Postoperative quality of life assessment
Time Frame: Up to 1 year postoperatively
|
Assessed using WHODAS2.0 scores at different time points after surgery
|
Up to 1 year postoperatively
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain scores of movement-evoked pain
Time Frame: During hospitalization
|
Assessed using NRS scale and BPI at different time points after surgery
|
During hospitalization
|
|
Pain scores at rest
Time Frame: During hospitalization
|
Using NRS scale and BPI at different time points after surgery
|
During hospitalization
|
|
Surgical site infection
Time Frame: During hospitalization
|
Defined according to the European Perioperative Clinical Outcome (EPCO) criteria
|
During hospitalization
|
|
Time of Bowel function recovery
Time Frame: During hospitalization
|
Defined as time to first defecation or flatus
|
During hospitalization
|
|
Sleep quality after surgery
Time Frame: Up to 1 year postoperatively
|
Assessed using the Pittsburgh Sleep Quality Index (PSQI) and the Morningness-Eveningness Questionnaire (MEQ) at different time points after surgery
|
Up to 1 year postoperatively
|
|
Postoperative anxiety assessment
Time Frame: Up to 1 year postoperatively
|
Assessed using GAD-7 scores at different time points after surgery
|
Up to 1 year postoperatively
|
|
Postoperative depression assessment
Time Frame: Up to 1 year postoperatively
|
Assessed using PHQ-9 scores at different time points after surgery
|
Up to 1 year postoperatively
|
|
Postoperative cognitive function assessment
Time Frame: Up to 1 year postoperatively
|
Assessed using AD-8 and three-word recall test scores at different time points after surgery
|
Up to 1 year postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Chunling Jiang, PhD, West China Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
November 15, 2024
Primary Completion (Estimated)
October 31, 2028
Study Completion (Estimated)
October 31, 2029
Study Registration Dates
First Submitted
October 5, 2024
First Submitted That Met QC Criteria
October 10, 2024
First Posted (Actual)
October 15, 2024
Study Record Updates
Last Update Posted (Actual)
October 15, 2024
Last Update Submitted That Met QC Criteria
October 10, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20241284
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.